Business Description
Telo Genomics Corp
NAICS : 621511
SIC : 8681
ISIN : CA88555C1077
Description
Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in the development and commercialization of diagnostic and prognostic products. The company is developing diagnostic and prognostic products for cancer and neurological disorders.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 39.24 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -6.6 | |||||
| 3-Year EPS without NRI Growth Rate | -7.7 | |||||
| 3-Year FCF Growth Rate | -5.8 | |||||
| 3-Year Book Growth Rate | 24.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.4 | |||||
| 9-Day RSI | 51.25 | |||||
| 14-Day RSI | 53.51 | |||||
| 6-1 Month Momentum % | -56 | |||||
| 12-1 Month Momentum % | -59.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.07 | |||||
| Quick Ratio | 5.07 | |||||
| Cash Ratio | 4.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19.9 | |||||
| Shareholder Yield % | 0.04 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -189.78 | |||||
| ROA % | -166 | |||||
| ROIC % | -3291.22 | |||||
| ROC (Joel Greenblatt) % | -3992.21 | |||||
| ROCE % | -185.72 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 10 | |||||
| Price-to-Tangible-Book | 9 | |||||
| EV-to-EBIT | -3.76 | |||||
| EV-to-EBITDA | -3.82 | |||||
| EV-to-FCF | -3.96 | |||||
| Price-to-Net-Current-Asset-Value | 9 | |||||
| Price-to-Net-Cash | 18 | |||||
| Earnings Yield (Greenblatt) % | -26.59 | |||||
| FCF Yield % | -21.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Telo Genomics Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.05 | ||
| Beta | 0.22 | ||
| Volatility % | 45.21 | ||
| 14-Day RSI | 53.51 | ||
| 14-Day ATR (C$) | 0.018006 | ||
| 20-Day SMA (C$) | 0.1705 | ||
| 12-1 Month Momentum % | -59.26 | ||
| 52-Week Range (C$) | 0.105 - 0.335 | ||
| Shares Outstanding (Mil) | 71.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Telo Genomics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Telo Genomics Corp Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Telo Genomics Corp Frequently Asked Questions
What is Telo Genomics Corp(TSXV:TELO)'s stock price today?
The current price of TSXV:TELO is C$0.18. The 52 week high of TSXV:TELO is C$0.34 and 52 week low is C$0.11.
When is next earnings date of Telo Genomics Corp(TSXV:TELO)?
The next earnings date of Telo Genomics Corp(TSXV:TELO) is .
Does Telo Genomics Corp(TSXV:TELO) pay dividends? If so, how much?
Telo Genomics Corp(TSXV:TELO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers